SS
Highly rated in
12
conditions
Highly rated in
12
conditions
Check Sam P. Schulman's experience treating your condition:
About Sam P. Schulman

Sam Schulman practices in Hamilton, Canada. Schulman is highly rated in 12 conditions, according to our data. His top areas of expertise are Mesenteric Venous Thrombosis, Venous Thromboembolism VTE, Deep Vein Thrombosis, Knee Replacement, and Hip Replacement.

His clinical research consists of co-authoring 284 peer reviewed articles and participating in 21 clinical trials in the past 15 years.

Locations
Hamilton Health Sciences, Hamilton, CA
Background & Education
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


21 Clinical Trials

Statins for Venous Event Reduction in Patients With Venous Thromboembolism
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
Phase II Study of Double Versus Single Reinitiation Dose of Warfarin After Interruption for Surgery
Management of Prothrombin Times Outside the Therapeutic Range in Patients on Warfarin and With Otherwise Stable Levels
Towards Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Abdominal or Pelvic Major Cancer Surgery
A Phase III, Multi-centre, Randomized Trial to Compare Rivaroxaban With Placebo for the Treatment of Symptomatic Leg Superficial Vein Thrombosis
A Single-site, Randomized Controlled Feasibility Trial of the Fearon Algorithm to Improve Management of Patients With Unstable Warfarin Effect.
Contention Alone Versus Anticoagulation for Symptomatic Calf Vein Thrombosis Diagnosed by Ultrasonography
Age-adjusted D-dimer Cutoff Levels to Rule Out Deep Vein Thrombosis: a Prospective Outcome Study
A Randomized Double-blind Study of 4-weekly Versus 12-weekly Monitoring of Stable Patients on Long-term Anticoagulation With Warfarin
Perioperative Anticoagulant (Dabigatran, Rivaroxaban, or Apixaban) Use for Elective Surgery/Procedure Evaluation in Patients With Atrial Fibrillation (AF) Part 2 Randomized Control Trial Pilot
Apixaban Versus Low-Molecular Weight Heparin For Thromboprophylaxis In Patients With Acute Spinal Cord Injury: A Pilot Study
View 19 Less Clinical Trials -

284 Total Publications



Save this expert for later
Sign Up
Looking for the best expert for you?
Start Here
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more